Citation 135287

HATTORI,M: YANG,XW: MIYASHIRO,H: NAMBA,T:. (1993). INHIBITORY EFFECTS OF MONOMERIC AND DIMERIC PHENYLPROPANOIDS FROM MACE ON LIPID PEROXIDATION IN VIVO AND IN VITRO.. 7(6)

Citation Details

Title	INHIBITORY EFFECTS OF MONOMERIC AND DIMERIC PHENYLPROPANOIDS FROM MACE ON LIPID PEROXIDATION IN VIVO AND IN VITRO.
Authors	HATTORI,M: YANG,XW: MIYASHIRO,H: NAMBA,T:
Year	1993
Volume	7
Issue	6

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN	EQUIVOCAL
2	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN	ACTIVE
3	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN	EQUIVOCAL
4	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRISTICIN	ACTIVE
5	SUPEROXIDE DISMUTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRISTICIN	ACTIVE
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ELEMICIN	WEAK ACTIVITY
7	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ELEMICIN	ACTIVE
8	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ELEMICIN	EQUIVOCAL
9	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTHRISCINOL	EQUIVOCAL
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTHRISCINOL	ACTIVE
11	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTHRISCINOL	EQUIVOCAL
12	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-TRANS-2-EN-1-OL,3-(3-4-5-TRIMETHOXY-PHENYL):	WEAK ACTIVITY
13	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-TRANS-2-EN-1-OL,3-(3-4-5-TRIMETHOXY-PHENYL):	ACTIVE
14	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-TRANS-2-EN-1-OL,3-(3-4-5-TRIMETHOXY-PHENYL):	INACTIVE
15	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-3-METHYL-2-(3-4-METHYLENEDIOXY-PHENYL)-5-(PROP-TRANS-1-ENYL):	ACTIVE
16	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-3-METHYL-2-(3-4-METHYLENEDIOXY-PHENYL)-5-(PROP-TRANS-1-ENYL):	EQUIVOCAL
17	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-3-METHYL-2-(3-4-METHYLENEDIOXY-PHENYL)-5-(PROP-TRANS-1-ENYL):	WEAK ACTIVITY
18	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-2-(3-METHOXY-4-5-METHYLENEDIOXY-PHENYL)-3-METHYL-5-(PROP-TRANS-1-ENYL):	WEAK ACTIVITY
19	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-2-(3-METHOXY-4-5-METHYLENEDIOXY-PHENYL)-3-METHYL-5-(PROP-TRANS-1-ENYL):	ACTIVE
20	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,TRANS-2-3-DIHYDRO: 7-METHOXY-2-(3-METHOXY-4-5-METHYLENEDIOXY-PHENYL)-3-METHYL-5-(PROP-TRANS-1-ENYL):	WEAK ACTIVITY
21	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL C	ACTIVE
22	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL C	ACTIVE
23	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL C	EQUIVOCAL
24	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIISOEUGENOL,DEHYDRO:	ACTIVE
25	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIISOEUGENOL,DEHYDRO:	ACTIVE
26	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIISOEUGENOL,DEHYDRO:	EQUIVOCAL
27	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	DIISOEUGENOL,DEHYDRO:	ACTIVE
28	SUPEROXIDE DISMUTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	DIISOEUGENOL,DEHYDRO:	ACTIVE
29	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL D	WEAK ACTIVITY
30	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL D	ACTIVE
31	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAGRANSOL D	INACTIVE
32	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-DIMETHOXY-PHENYL):	EQUIVOCAL
33	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-DIMETHOXY-PHENYL):	ACTIVE
34	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-DIMETHOXY-PHENYL):	INACTIVE
35	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	EQUIVOCAL
36	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	EQUIVOCAL
37	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-OL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	WEAK ACTIVITY
38	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-3-DIOL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	WEAK ACTIVITY
39	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-3-DIOL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	ACTIVE
40	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPAN-1-3-DIOL,ERYTHRO: 2-(4-ALLYL-2-6-DIMETHOXY-PHENOXYL)-1-(3-4-5-TRIMETHOXY-PHENYL):	WEAK ACTIVITY
41	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL B	ACTIVE
42	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL B	INACTIVE
43	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL B	INACTIVE
44	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL A	ACTIVE
45	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL A	ACTIVE
46	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICANOL A	INACTIVE
47	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN,7-HYDROXY:	ACTIVE
48	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN,7-HYDROXY:	ACTIVE
49	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTICIN,7-HYDROXY:	INACTIVE

Citation 135287

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1